Research ArticleArticle
Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis
Anne G. Semb, Silvia Rollefstad, Sella A. Provan, Tore K. Kvien, Einar Stranden, Inge C. Olsen and Jonny Hisdal
The Journal of Rheumatology January 2013, jrheum.120621; DOI: https://doi.org/10.3899/jrheum.120621
Anne G. Semb
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Silvia Rollefstad
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Sella A. Provan
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Tore K. Kvien
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Einar Stranden
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Inge C. Olsen
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Jonny Hisdal
From the Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker; and Faculty of Medicine, University of Oslo, Oslo, Norway. Dr. Semb has received speaker’s honoraria and/or consulting fees from Merck/Schering-Plough, Abbott, BMS, Pfizer, and Roche. J. Hisdal has received speaker’s honoraria from Pfizer. Dr. Provan has received speaker’s honoraria from Abbott, BMS, and Roche. Dr. Kvien has received speaker’s and/or consulting honoraria and/or research grants from Abbott, BMS, Merck/Schering-Plough, Pfizer, Roche, UCB, and Wyeth. E. Stranden has received speaker’s honoraria from Pfizer, 3M, and Meda and university sponsorship from Hoechts. A.G. Semb, MD, PhD; S. Rollefstad, Medical Student; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, Faculty of Medicine, University of Oslo; E. Stranden, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker, Faculty of Medicine, University of Oslo; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, PhD, Section of Vascular Investigations, Oslo Vascular Centre, Oslo University Hospital Aker. Address correspondence to Dr. A.G. Semb, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, NO-0319 Oslo, Norway. E-mail: a-semb@diakonsyk.no. Accepted for publication November 19, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis
Anne G. Semb, Silvia Rollefstad, Sella A. Provan, Tore K. Kvien, Einar Stranden, Inge C. Olsen, Jonny Hisdal
The Journal of Rheumatology Jan 2013, jrheum.120621; DOI: 10.3899/jrheum.120621